Organoidsciences Ltd. (KOSDAQ:476040)
South Korea
· Delayed Price · Currency is KRW 22,950
-650 (-2.75%)
At close: Apr 28, 2026
Organoidsciences Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 5,238 | 1,946 | 2,453 | 4,995 |
| Short-Term Investments | 224.56 | 4,363 | 16,724 | 25,434 |
| Trading Asset Securities | 13,154 | 9,891 | 3,121 | - |
| Cash & Short-Term Investments | 18,616 | 16,199 | 22,298 | 30,429 |
| Cash Growth | 14.92% | -27.35% | -26.72% | - |
| Accounts Receivable | 320.22 | 230.51 | 442.77 | 49.27 |
| Other Receivables | 235.21 | 53.39 | 218.35 | 298.55 |
| Receivables | 555.43 | 283.9 | 661.12 | 347.82 |
| Inventory | - | - | 26.23 | - |
| Prepaid Expenses | 231.06 | 225.31 | 118.65 | 243.44 |
| Other Current Assets | 571.23 | 189.27 | 269.46 | 115.87 |
| Total Current Assets | 19,974 | 16,898 | 23,373 | 31,136 |
| Property, Plant & Equipment | 8,464 | 7,212 | 7,874 | 7,381 |
| Long-Term Investments | 6,636 | 3.3 | 0 | -0 |
| Other Intangible Assets | 573.26 | 527.29 | 295.56 | 110.29 |
| Long-Term Accounts Receivable | -0 | -0 | -0 | - |
| Other Long-Term Assets | 1,547 | 1,252 | 1,213 | 1,132 |
| Total Assets | 37,194 | 25,892 | 32,755 | 39,760 |
| Accounts Payable | 65.59 | 17.03 | 14.88 | - |
| Accrued Expenses | 397.96 | 297.57 | 332.45 | 158.58 |
| Short-Term Debt | 3,000 | 3,000 | 300 | 300 |
| Current Portion of Long-Term Debt | 333.24 | 167.18 | - | - |
| Current Portion of Leases | 249 | 440.26 | 378.71 | 502.43 |
| Current Income Taxes Payable | - | - | 0.74 | - |
| Other Current Liabilities | 3,476 | 1,129 | 62,242 | 38,253 |
| Total Current Liabilities | 7,522 | 5,051 | 63,269 | 39,214 |
| Long-Term Debt | 2,200 | 2,533 | 2,000 | 2,000 |
| Long-Term Leases | 1,272 | 1,952 | 2,207 | 1,523 |
| Pension & Post-Retirement Benefits | 859.36 | 870.96 | 569.81 | 305.66 |
| Other Long-Term Liabilities | 496.43 | 192.63 | 313.58 | 260.6 |
| Total Liabilities | 12,350 | 10,600 | 68,360 | 43,303 |
| Common Stock | 3,293 | 2,635 | 1,433 | 1,433 |
| Additional Paid-In Capital | 126,152 | 101,753 | 85.06 | 85.06 |
| Retained Earnings | -107,034 | -91,664 | -80,409 | -41,740 |
| Comprehensive Income & Other | 2,252 | 2,589 | 1,553 | 661.66 |
| Total Common Equity | 24,662 | 15,313 | -77,338 | -39,560 |
| Minority Interest | 182 | -19.92 | 69.14 | - |
| Shareholders' Equity | 24,844 | 15,293 | -35,604 | -3,543 |
| Total Liabilities & Equity | 37,194 | 25,892 | 32,755 | 39,760 |
| Total Debt | 7,054 | 8,092 | 4,886 | 4,325 |
| Net Cash (Debt) | 11,562 | 8,107 | 17,412 | 26,104 |
| Net Cash Growth | 42.61% | -53.44% | -33.30% | - |
| Net Cash Per Share | 1893.61 | 1939.83 | 6075.69 | 9108.91 |
| Filing Date Shares Outstanding | 6.57 | 5.27 | 2.87 | 2.87 |
| Total Common Shares Outstanding | 6.57 | 5.27 | 2.87 | 2.87 |
| Working Capital | 12,452 | 11,846 | -39,896 | -8,077 |
| Book Value Per Share | 3752.50 | 2905.63 | -26986.45 | -13804.25 |
| Tangible Book Value | 24,089 | 14,785 | -77,633 | -39,671 |
| Tangible Book Value Per Share | 3665.28 | 2805.58 | -27089.59 | -13842.74 |
| Land | 837.27 | 837.27 | 837.27 | 837.27 |
| Buildings | 1,838 | 1,838 | 1,838 | 1,838 |
| Machinery | 3,563 | 2,516 | 1,970 | 1,552 |
| Construction In Progress | 1,787 | 25.1 | 202.09 | 268.2 |
Source: S&P Capital IQ. Standard template. Financial Sources.